Your browser doesn't support javascript.
loading
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
Kayser, Sabine; Kramer, Michael; Martínez-Cuadrón, David; Grenet, Justin; Metzeler, Klaus H; Sustkova, Zuzana; Luskin, Marlise R; Brunner, Andrew M; Elliott, Michelle A; Gil, Cristina; Marini, Sandra Casal; Rácil, Zdenek; Cetkovsky, Petr; Novak, Jan; Perl, Alexander E; Platzbecker, Uwe; Stölzel, Friedrich; Ho, Anthony D; Thiede, Christian; Stone, Richard M; Röllig, Christoph; Montesinos, Pau; Schlenk, Richard F; Levis, Mark J.
Afiliação
  • Kayser S; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelbe
  • Kramer M; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Martínez-Cuadrón D; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid.
  • Grenet J; Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Metzeler KH; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich.
  • Sustkova Z; Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Brunner AM; Massachusetts General Hospital, Boston, MA.
  • Elliott MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Gil C; Hospital General, Alicante.
  • Marini SC; Department of Clinical Haematology, Centro Hospitalar e Universitário de Coimbra, Coimbra.
  • Rácil Z; Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Cetkovsky P; Department of Internal Medicine and Haematology, 3rd Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady, Charles University Prague, Czech Republic.
  • Novak J; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Perl AE; Division of Hematology and Oncology, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Platzbecker U; Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig.
  • Stölzel F; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Ho AD; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.
  • Thiede C; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Röllig C; Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden.
  • Montesinos P; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain; CIBERONC, Instituto Carlos III, Madrid.
  • Schlenk RF; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hosp
  • Levis MJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
Haematologica ; 107(4): 836-843, 2022 04 01.
Article em En | MEDLINE | ID: mdl-34348451
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article